Infant transplant law may change with new test planTaipei TimesBrain death — either just the brainstem or the entire brain — is a condition describing the absence of all brain activity and results in neuronal necrosis after the brain is deprived of…
On Day of Transplant, Man's Heart Heals Itself
Omaha, N.E. (ABC News) — “If he had come to us any later, his heart would have just stopped,” Dr. John Um, Surgical Director of Heart Transplantation at Nebraska Medical…
Determined organ donor – Mmegi Online
Mmegi OnlineDetermined organ donorMmegi OnlineSpeaking to Mmegi in an interview just before he left, Bevan Asekeng said that he believed he was going to learn a lot from the workshop."I believe that when I come back to Botswana, I will have learnt…
Boston Scientific Launches Drug Eluting Stent Solution to Treat Severe Lesions … – Businessweek
Boston Scientific Launches Drug Eluting Stent Solution to Treat Severe Lesions …BusinessweekBoston Scientific has launched in European countries the PROMUS ELEMENT(TM) PLUS BTK (Below The Knee) Everolimus-Eluting Stent System for the treatment of cer…
Persistence pays out exercise benefits in heart failure – News-Medical.net
Persistence pays out exercise benefits in heart failureNews-Medical.netBy Eleanor McDermid, Senior medwireNews Reporter. Health benefits derived from regular exercise accumulate over the long term, shows a 10-year study in patients with heart failure (…
Report: Ohio nurse didn't realize she discarded kidney
A nurse who accidentally disposed of a living donor's kidney during a transplant said she didn't realize it was in chilled, protective slush that she removed from an operating room, took down a hall to a dirty utility room and "flushed dow…
Seattle Genetics and Millennium Complete Enrollment in Phase III AETHERA Trial of ADCETRIS® for Post-Transplant …
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited , today announced the completion of patient enrollment in a phase III clinical trial of ADCETRIS for post-transplant …
Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release … – Sacramento Bee
Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release …Sacramento BeeDeveloped by Astellas, tacrolimus extended release capsules are a once daily formulation of calcineurin-inhibitor immunosuppressant tacrolimus. The NDA submissi…
Barfi's success is humbling; response was unexpected: Basu – Moneycontrol.com
IBTimes IndiaBarfi's success is humbling; response was unexpected: BasuMoneycontrol.com… Basu's latest film Barfi has charmed both filmgoers and critics alike. Combining modern outlook and cinematic aesthetics with a traditional Indian sensib…
Cell Therapeutics' phase 1 study of pacritinib shows encouraging anti-tumour … – pharmabiz.com
Cell Therapeutics' phase 1 study of pacritinib shows encouraging anti-tumour …pharmabiz.comPatients had relapsed following a median of five prior therapies (range 2-15); 44% had failed prior stem cell transplant and 52% were rituximab refractory….